This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Piramal Enterprises Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Kishorkumar Shivajirao Kadam: Innovator in Pharmaceutical Science
Introduction
Kishorkumar Shivajirao Kadam is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target specific enzymes related to various diseases. With a total of 2 patents to his name, his work is recognized for its potential impact on medical treatments.
Latest Patents
Kadam's latest patents include innovative compounds that serve as inhibitors for diacylglycerol acyltransferase (DGAT). The first patent focuses on isoxazole, thiazole, and oxidiazole derivatives, detailing processes for their preparation and their use as medicaments. These compounds are particularly aimed at preventing and treating diseases mediated by DGAT, especially DGAT1. The second patent describes carboxy oxazole or thiazole compounds as DGAT-1 inhibitors, which are useful in the treatment of obesity. This patent also outlines the processes for their preparation and pharmaceutical compositions containing these heteroaryl compounds.
Career Highlights
Kishorkumar Kadam is currently associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His work at Piramal has allowed him to focus on innovative research and development, contributing to advancements in drug discovery and therapeutic solutions.
Collaborations
Kadam has collaborated with several professionals in his field, including notable coworkers such as Ravindra Dnyandev Jadhav and Rajiv Sharma. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Kishorkumar Shivajirao Kadam stands out as a significant figure in pharmaceutical innovation. His contributions through patents and collaborative efforts highlight his commitment to advancing medical science and improving treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
